Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
about
Perianal injectable bulking agents as treatment for faecal incontinence in adultsPerianal injectable bulking agents as treatment for faecal incontinence in adultsTreatment of fecal incontinence - review of observational studies (OS) and randomized controlled trials (RCT) related to injection of bulking agent into peri-anal tissueNew options for the treatment of fecal incontinenceAnal Sphincter Augmentation Using Biological MaterialInternal anal sphincter augmentation and substitution.Anorectal injury following pelvic radiotherapy.Management of fecal incontinenceNovel bulking agent for faecal incontinenceInjectable silicone biomaterial for faecal incontinence due to internal anal sphincter dysfunction.Review article: Recent trends in diagnosis and treatment of faecal incontinence.Advances in the surgical treatment of fecal incontinence.The etiology, assessment, and treatment of fecal incontinence.Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of ratsPilot study of two new injectable bulking agents for the treatment of faecal incontinence.Multicentre observational study of the Gatekeeper for faecal incontinence.Systematic review of perianal implants in the treatment of faecal incontinence.Current status: new technologies for the treatment of patients with fecal incontinence.The use of Permacol® injections for the treatment of faecal incontinence.Effects of ovariectomy and hormone replacement on submucosal collagen and blood vessels of the anal canal of rats.Comparison of bulking agents in the treatment of fecal incontinence: a prospective randomized clinical trial.Evaluation of the use of PTQ implants for the treatment of incontinent patients due to internal anal sphincter dysfunction.Permanent sacral nerve stimulation for fecal incontinence.The procon incontinence device: a new nonsurgical approach to preventing episodes of fecal incontinence.
P2860
Q24200587-A9368224-231D-4699-8BCA-DC0AE6F6D4DEQ24235376-576D8AD6-0966-4C2B-A719-8F1E73DD4405Q24622508-596847C1-B1CC-4AF5-BEAF-30859475ED53Q24633498-8B00C8B3-6024-4C40-A0E8-8953A11A52E9Q26774397-1CB59F9D-2B4D-4028-882A-FDBBCFDA2D0EQ33607178-D87D2EA1-FA79-426B-98D3-98F893529182Q34328065-F7707E00-10C0-4339-B3FA-9D07800A4337Q35014637-DEFECE4F-E6D9-4127-81A0-6A78102FE1A9Q35590199-E15F38C4-EF71-44F7-9AB3-04AC816D4C85Q35594857-E7F4123D-1ACD-4168-9250-BE23D5635DDEQ35744445-3AE40180-7074-4F87-A5A2-0A6C094326A6Q36104492-B763759C-F9F1-435A-B640-99E2A5283317Q36342337-2A3051FE-6DD2-4D5D-BFC6-AA3B065CA17BQ36839060-D3EF5494-A6CD-42FC-AFB0-CDC4A7F1BEC3Q36892920-C4779B8E-E2FF-4B8A-B9D0-9E0C3A73670BQ37337411-738A6896-C6D8-40E8-9AA0-FBF006DA30C1Q37941477-221B3440-6E47-48D0-8DB9-699A7B0FFD25Q38194462-7176DB2A-C4B7-4197-8D60-EA5BA78C9215Q43348918-D47BCE77-CC42-479B-94D4-D2140F409494Q45135491-A6CD4181-5937-4C06-9F07-B53F67FA1CAAQ48023709-43FB5FA8-D65F-4E97-A677-E0BC77DBCCD2Q50962645-C949C6D7-23EB-4EA6-85A8-05E2B41C9ED7Q52539682-5FC1BF8B-086D-41B1-A223-127B4CF257FAQ53414247-A10B092F-13C6-4480-9195-EF5776B84FB4
P2860
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
@en
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
@nl
type
label
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
@en
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
@nl
prefLabel
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
@en
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
@nl
P2093
P2860
P1476
Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2168.1998.00751.X
P407
P577
1998-07-01T00:00:00Z